facebook twitter linkedin
  • images/stories/slider.png
  • images/stories/slider2.png
  • images/stories/slider3.png
  • images/stories/slider4.png

NEWS RELEASES

  • Selvita Inc. wins medicinal chemistry contract in San Francisco

    Kraków, Poland - July 11, 2016 - Selvita Inc., with headquarters in Cambridge, MA. and a Client based in San Francisco, CA, signed an agreement for drug discovery collaboration involving medicinal chemistry services. The contract will be carried out…

    Read More...

  • Selvita epigenetic project is the first Polish drug target program selected by EU Lead Factory

    Kraków, Poland – June 06, 2016 – The European Lead Factory, a scientific consortium dedicated to supporting the discovery of innovative medicines, has selected the first drug target program from Poland, to perform high throughput screening. The selec…

    Read More...

  • Selvita to present at the Annual BIO International Convention 2016

    Krakow, 27 May 2016 - Selvita S.A. (WSE: SLV), the largest drug discovery company in Central and Eastern Europe, will participate and present at the upcoming Annual BIO International Convention, taking place on June 6-9, 2016, at the Moscone Center i…

    Read More...